OSLO, Norway, May 3, 2023 /PRNewswire/ — Lytix Biopharma – Lytix Biopharma AS (“Lytix”) (Euronext Growth Oslo: LYTIX), a Norwegian immuno-oncology company – is pleased to announce that Dr Øystein Rekdal, CEO in Lytix Biopharma, today will give an oral presentation at the `Frontiers in…